{
    "title": "CSL flags higher costs after FY profit dip",
    "url": "https://www.dailymail.co.uk/wires/aap/article-11118123/CSL-year-net-profit-dips.html",
    "date": "2022-08-16",
    "keywords": [
        "year",
        "plasma",
        "cent",
        "profit",
        "blood",
        "company",
        "share",
        "csl",
        "collection",
        "business",
        "growth",
        "perreault",
        "vaccine",
        "capacity",
        "manufacturing",
        "supply",
        "csls",
        "revenue",
        "core",
        "basis",
        "mr",
        "dividend",
        "contribution",
        "acquisition",
        "pharma",
        "deal",
        "b",
        "biotech",
        "giant",
        "decline",
        "increase",
        "post",
        "covid",
        "demand",
        "paul",
        "wednesday",
        "chain",
        "compression",
        "unit",
        "maker",
        "companys",
        "slump",
        "health",
        "onset",
        "covid19",
        "disruption",
        "drop",
        "pandemic",
        "fy21",
        "fy22",
        "nature",
        "cycle",
        "currency",
        "news",
        "afternoon",
        "trading",
        "aest",
        "rebound",
        "half",
        "immunoglobulin",
        "albumin",
        "momentum",
        "future",
        "performance",
        "seqirus",
        "record",
        "volume",
        "time",
        "steady",
        "outlook",
        "vifor",
        "month",
        "nephrology",
        "cardiology",
        "product",
        "portfolio",
        "briefing",
        "guidance",
        "change",
        "view",
        "pct",
        "a322",
        "total",
        "a1503",
        "us118"
    ],
    "category": [
        "wires",
        "aap"
    ]
}